CED coverage of the April 2026 interim reclassification of state-licensed medical cannabis and FDA-approved products to Schedule III, the reclassification this hearing builds on.Read the rescheduling coverageSchedules of Controlled Substances: Rescheduling FDA-Approved Marijuana Products Background on the federal scheduling framework referenced throughout this commentary, useful for readers who want the regulatory context in more depth.Read the scheduling explainerMedical Cannabis: What to Tell Your Patients CED guidance for clinicians navigating cannabis conversations with patients while the evidence base and legal landscape continue to evolve.Read the clinical counseling guide Frequently Asked QuestionsDid the DEA finish rescheduling marijuana in July 2026?No
Mast Cell: A Multi-Functional Master Cell. Frontiers in Immunology, vol
Drew went to rehab at the age of 13, attempted suicide, and after a successful juvenile court petition for emancipation, she moved into her own apartment when she was 15
In that role, he will spearhead the launch of LarkVantage, a platform designed to mitigate the challenges associated with utilization reviews for GLP-1s
Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis
Lake Mary is one of Central Floridas most sought-after communities, known for top-rated Seminole County schools, a low crime rate, and a family-friendly atmosphere